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  Recent  global  warming  trends  may  have  a  significant 
impact  on  vector-borne  viral  diseases,  possibly  affecting 
vector population dynamics and disease transmission. This 
study measured levels of hemagglutination-inhibition (HI) 
antibodies against Japanese encephalitis virus (JEV) and 
neutralizing antibodies against Akabane virus (AKAV) and 
Aino virus (AINV) for Thoroughbred horses in Korea. Blood 
samples  were  collected  from  989  racehorses  in  several 
provinces, between October 2005 and March 2007. Sera 
were tested using either an HI assay or a virus neutralization 
test.  Approximately  half  (49.7%;  492/989)  of  the  horses 
tested were antibody-positive for JEV. The HI titer against 
JEV was significantly correlated with racehorse age (p ＜ 
0.05). Horses with an HI antibody titer of 1：160 or higher 
accounted for 3.9% of the animals tested, indicating that 
vectors transmitting arthropod- borne viruses bit relatively 
few horses. In contrast, 3.8% (19/497) and 19.5% (97/497) of 
horse sera collected in March 2007 were positive against 
AKAV and AINV, respectively. The presence of antibodies 
against AKAV and AINV may indicate the multiplication of 
AKAV and AINV in these horses.
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Introduction
  Populations of Korean horses, including native ponies, 
have been gradually increasing with the growth of the 
racing industry. Approximately 23,000 horses including 
8,000 Thoroughbred horses and 15,000 other breeds (Jeju 
horses and Jeju racehorses) are raised on 1,142 premises in 
Korea [12]. Racehorses are important industrial animals in 
Korea, and therefore great care has been taken to prevent 
arbovirus infections in these animals. However, there is 
growing concern that global warming may affect the 
prevalence of vector-borne diseases and, consequently, the 
racehorse industry.
  Japanese encephalitis virus (JEV) is a Flavivirus belonging 
to the family Flaviviridae. Japanese encephalitis (JE) is a 
typical zoonosis caused by JEV and is transmitted by several 
species of mosquito, principally Culex tritaeniorhynchus, 
which breed in small pools or paddy fields [16]. JEV can 
infect both domestic and wild animals, including swine, 
horses, chickens, reptiles, and grey herons. Although adult 
animals do not develop clinical signs, they may serve as viral 
reservoirs or amplifying hosts. After JEV was first identified 
in Koreans in 1946, a number of JE cases were reported in 
domestic animals as well as in humans through the 1950s and 
1960s [9]. When an attenuated live vaccine was developed 
and administered to both swine and horses in 1980, the 
number of outbreaks in animals was significantly reduced 
[8]. Recently, JEV has been considered an emerging virus, 
with new JE cases being reported in regions of Australia and 
Africa [15]. JEV has been identified from a diseased horse 
in Japan in 2006 [19] and JEV antibodies were detected in 
52% of Indonesian horses [18]. A horse that is naturally 
infected with JEV displays several symptoms, such as 
anorexia, lethargy, and fever, and is considered to be a 
dead-end host [19]. There have been no reports on horses that 
were clinically infected with JEV in Korea until recently; 
however, there are reports of other infected animals in Korea 
[20,21] 
    Akabane virus (AKAV) and Aino virus (AINV) are 
members of the Simbu serogroup, genus Orthobunyavirus, 
family Bunyaviridae, and consist of three segments of 
single-stranded negative RNA. These two viruses are 
responsible for many reproductive disorders, including 
abortion, stillbirth, and congenital malformation, in 
ruminants [13]. AKAV and AINV are transmitted via 
biting midges such as Culicoides  (C.) brevitarisis, C. 
oxystoma, and C. nebulous [7]. Although AKAV and 
AINV are not known to cause illness in horses, there have 382    Dong-Kun Yang et al.
been several reports on the presence of antibodies against 
arboviruses in these animals [2,3].
  The risk of exposure of domestic animals to arbovirus- 
infected mosquito bites depends on several environmental 
factors, including climate, host abundance, and vector 
populations. Among the arboviruses, JEV, AKAV, and AINV 
are the most significant vector-borne viral agents in South 
Korea. Sero-epidemiological studies are critical for predicting 
potential outbreaks of vector-borne viral diseases among 
horses. These studies also provide data for establishing a 
system to prevent these diseases. In our study, we conducted 
a serological survey to determine the prevalence of 
antibodies against JEV, AKAV, and AINV in Thoroughbred 
horses in Korea.
Materials and Methods
Viruses and cells 
  The strain of JEV used as an antigen for the hemagglutination 
inhibition test was KV1899. This particular strain was 
isolated from Korean pig blood in 1999 [20]. The strains of 
Akabane and Aino viruses used for the virus neutralization 
test were K-9 and KSA9910, respectively [11]. The latter 
two viruses were propagated using Vero cells cultured in 
α-minimum essential medium (MEM; Gibco BRL, USA) 
supplemented with antibiotics (100 IU/ml penicillin and 100 
μg/ml streptomycin), an antimycotic (0.25 μg/ml amphotericin 
B), and 5% fetal bovine serum (FBS; Gibco BRL, USA). 
Uninfected cell cultures were used as negative controls. 
Collection of sera
  For the seroprevalence study, blood samples were collected 
from thoroughbred racehorses in several provinces of 
Korea, between October 2005 and March 2007. The species 
of racehorse tested in this study was Thoroughbred, and 
about 70% of the racehorses were produced in Korea; the 
others were imported from several countries such as the 
United State of America, Australia, Japan, New Zealand, 
India and Ireland. Most of the racehorses are vaccinated once 
a year against Streptococcus equi, JEV and equine influenza 
virus. None of the horses used in this study had been 
vaccinated against AKAV or AINV. Clotted blood samples 
were separated by centrifugation, and the sera were stored 
at -20
oC until use.
Hemagglutination inhibition (HI) test
  To estimate JEV antibody prevalence in horse sera samples, 
an HI test was performed in 96-well microplates, using 
slightly modified standard methods. Using a sucrose- 
acetone extraction method, viral antigens were prepared 
from the brains of suckling mice infected with the Korean 
isolate of strain KV1899 [1,20]. Briefly, the sera were treated 
in round bottom microplates (96-well). To remove non- 
specific inhibitors, 10 μl of serum and 50 μl of 4% bovine 
albumin were mixed with 40 μl of 25% kaolin (Sigma, USA) 
and incubated for 30 min. After pipetting, the kaolin was 
removed by centrifugation at 3,600 rpm for 15 min in a 
microfuge. The resultant clear supernatant was mixed with 
5 μl of packed goose erythrocytes to remove any natural 
agglutinins. After incubation for 1 h at 37
oC, the treated 
serum was separated from the goose erythrocytes by 
centrifugation. For the HI test, four to eight HA units of JEV 
(in 25 μl) were added to 25 μl of treated serum. After 
incubation for 1 h at 37°C, 50 μl of 0.33% goose erythrocytes 
were added, and the microplates were incubated at 37
oC for 
30 min. The HI titer was expressed as the reciprocal of the 
highest dilution of serum showing complete inhibition of 
hemagglutination. An HI titer of 1：20 or higher was 
considered positive.
Virus neutralization (VN) test
  The VN tests for AKAV and AINV were carried out in 
96-well microplates using Vero cells [11]. A 50 μl aliquot 
of a two-fold serial dilution of heat-inactivated serum was 
mixed with an equal volume of 200 TCID50 of each virus and 
incubated at 37
oC for 1 h. A total of 100 μl of Vero cells in 
α-MEM containing 10% FBS were then added to each well 
at a concentration of 200,000 cells per ml. The microplates 
were incubated for 5 days at 37
oC under 5% CO2, after which 
time virus-induced cytopathic effects were evaluated 
visually. The VN titer was expressed as the reciprocal of the 
highest serum dilution that completely inhibited cytopathic 
effects in the wells. The serum dilution ranged from 1：2 
to 1：64, and an antibody titer higher than 1：2 was 
considered positive.
Statistical analysis
  Chi-squared tests were used to analyze differences in 
seroprevalence between the sexes, ages, and provinces, 
respectively. A p-value less than 0.05 was considered to be 
statistically significant.
Results
Seroprevalence of JEV
  Approximately half (49.7%; 492/989) of all horses tested 
were positive for JEV; there were no significant differences 
in JEV seroprevalence by year (p ＞ 0.05). Horses with an HI 
titer of 1：160 or higher accounted for only 3.9% of the 
animals tested (Table 1). The HI titer against JEV increased 
with increasing racehorse age (p ＜ 0.05; Fig. 1). This age- 
dependent trend was consistent with sera obtained in two 
subsequent years, but the positive relationship tended to be 
higher in 2006 than in 2007 (p ＜ 0.05; Fig. 1).
  No differences were found among females, males, and 
geldings with respect to JEV antibody prevalence (p ＞ 0.05; 
Fig. 2). JEV antibody rates were numerically higher in 
Gyeongnam province as compared to Jeju and Gyeonggi Serosurveillance for Arbo viruses in Thoroughbred horses    383
Fig. 1. Distribution of hemagglutination-inhibition titer by age 
among Thoroughbred horses that were positive against Japanese 
encephalitis virus in 2006 and 2007. 
Fig. 2.  Seropositive rates for Japanese encephalitis virus (JEV), 
Aino virus (AINV) and Akabane virus (AKAV) grouped by 
gender among 497 Thoroughbred horses whose blood samples 
were collected in 2007.
Table 1. Seroprevalence and distribution of hemagglutination inhibition titer against Japanese encephalitis virus in serum samples 
collected from Thoroughbred horses between 2005 and 2007 in Korea
Year
No. of 
samples
No. of positive 
samples(%)
Hemagglutination inhibition titer
＜1：20 1：20 1：40 1：80 1：160 1：320 1：640 1：1,280
2005
2006
2007
Total
230
262
497
989
122 (53.0)
132 (50.4)
238 (47.9)
492 (49.7)
108
130
259
497
45
44
 86
175
 47
 32
 82
161
 25
 40
 52
117
  2
12
15
29
2
4
2
8
1
0
1
2
0
0
0
0
Fig. 3.  Regional distribution of Japanese encephalitis virus 
(JEV), Aino virus (AINV) and Akabane virus (AKAV) antibodies
from Thoroughbred horses in 2007. GG:Gyeonggi province, 
GN: Gyeungnam province, JJ: Jeju province. 
provinces, but statistical differences between regions were 
not observed: Gyeongnam, 58.1% (97/167); Jeju, 51.5% 
(34/66); and Gyeonggi provinces, 40.5% (107/264) (χ
2 = 
4.54, df = 2, p = 0.103; Fig. 3).
Seroprevalence of Akabane and Aino viruses
  Seroprevalence against AKAV and AIV was examined in 
sera obtained in March 2007 from 497 racehorses. The 
seropositive rates for AKAV and AINV individually were 
3.8% (19/497) and 19.5% (97/497), respectively (Table 2). 
AINV antibody rates were relatively low compared with 
those of JEV: Gyeongnam, 26.9% (45/167); Jeju, 19.7% 
(13/66); and Gyeonggi provinces, 14.8% (39/264) (χ
2 = 
6.37, df = 2, p = 0.042; Fig. 3). AKAV antibody rates were 
lowest among those of the viruses: Gyeongnam, 7.8% 
(13/167); Gyeonggi, 2.3% (6/264): and Jeju provinces, 0% 
(0/66); (χ
2 = 10.5, df = 2, p = 0.005; Fig. 3).
Discussion
  Most of the racehorses raised in Korea are vaccinated with 
a live attenuated JE vaccine in May of each year. The 
seropositive rates found in this study ranged from 53.5 to 
47.9% over the course of 3 years and were similar to rates 
obtained in a 1985 survey [14]. Sugiura and Shimada [17] 
reported that horses showing a titer of 1：1,280 or higher 
were classified as infected with field JEV. JE vaccine 384    Dong-Kun Yang et al.
Table 2. Distribution of serum neutralizing titers against Akabane and Aino viruses in Thoroughbred horses
Pathogen No. of samples
No. of positive 
samples (%)
Serum neutralizing titer
＜1：21 ：21 ：41 ：81 ：16 1：32 1：64
Akabane virus
Aino virus
497
497
19 (3.8)
97 (19.5)
478
400
16
50
  3
30
  0
11
0
5
0
1
0
0
produced in Japan is killed vaccine and is known to induce 
an HI titer of less than 1：640. Therefore, the Japanese 
scientists considered that a titer of 1：1,280 or higher was 
induced by JEV infection. In contrast to Japanese JE 
vaccine, Korean JE vaccine is live vaccine and most of the 
antibody titers induced by Korean JE vaccine are less than 
1：160 [8]. In addition, Yamanaka et al. [19] reported that 
horses infected with JEV induced SN antibody titers from 
1：160 to 1：640. Moreover, most of the Korean racehorses 
have been vaccinated against JEV and the antibody induced 
by JEV infection can not be differentiated from the one 
induced by JEV vaccination. After full consideration of the 
previous reports, we concluded that an HI titer greater than 
1：160 could be a meaningful titer, one that could be 
induced by JEV infection. In our study, racehorses showing 
antibody titers equal to or higher than 1：160 accounted for 
only 3.9% of horses tested. There were no horses with HI 
antibody titers higher than 1：1,280 and clinical illness due 
to JEV infection, indicating that JEV infection is not 
widespread among South Korean racehorses at this time. 
The presence of antibodies to JEV non-structural 1 (NS1) 
protein also has been considered an indicator of natural JEV 
infection among populations vaccinated with inactivated JE 
vaccine [5,6]. However, because a live attenuated JE 
vaccine, named as Anyang 300 strain, has been inoculated 
into horses at every spring season since 1980, it is not able 
to be applied the detection methods of the NS1 antibodies 
for differentiating vaccinated horses from naturally infected 
horses in Korea. In this study, the seroprevalence of JEV was 
significantly correlated with racehorse age, indicating either 
an immune response against repeated vaccinations or JEV 
infection. Continuous serosurveillance of JEV has been 
reported for goats and wildlife species in Korea [10,21]. 
Therefore, we predict that clinical JEV infection could 
appear in horses at any time.
  Neutralizing antibodies against AKAV have been observed 
in many countries in buffalo, sheep, camels, and cattle. 
Relatively high incidence rates of antibodies against AKAV, 
ranging from 50 to 85%, have also been reported for horses 
[2,3]. In the present study, we observed a low prevalence 
(3.8%) and low antibody titers (≤1：4) in the racehorses 
we examined. These data suggest that either the virus 
replicates at a low level in horses or only a small number of 
horses are exposed to mosquitoes infected with AKAV.
  AINV is a member of the Simbu serogroup and causes 
congenital defects in calves. Thirty three percent of dairy 
cattle in Japan had a positive reaction in the serosurveillance 
for AINV [4]. According to a study by Cybinski et al. [2], 
specific antibodies against AINV have been detected in 
cattle, sheep, and goats, but not in Australian horses. In 2006, 
seropositive rates against AINV were 17.8% and 24.3% in 
Korean goats and cattle, respectively (data not shown). Our 
results demonstrate the presence of AINV antibodies in 
horses (19.5%). Regional prevalence rates ranged from 14.8 
to 26.9%, indicating that horses seropositive for AINV are 
widely distributed throughout the country. We can also infer 
that vectors transmitting AINV are active in the provinces 
surveyed. 
  In conclusion, the present results suggest that the incidence 
rate of antibody against AINV infection is much higher 
(about 20%) than those of antibodies to AKAV and JEV 
infection (about 4%). Further studies are necessary to model 
and predict the transmission of vector-borne viral diseases 
between horses and mosquitoes. The effects of climate 
change on the distribution and disease transmission of 
vectors in the Korean Peninsular region should also be 
surveyed in the near future.
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